Insider Sale: Director at $COHR Sells 1,000 Shares

Director Howard H. Xia sold 1,000 shares of $COHR on 06-11-2025 for approximately $83,000, representing about 2.1% of their holdings. Over the past six months, $COHR insiders have executed 11 sales and no purchases, while hedge fund activity in Q1 2025 showed significant portfolio adjustments, with DODGE & COX reducing its stake by 37.1% and WELLINGTON MANAGEMENT GROUP LLP increasing its position by 83.8%. Wall Street analysts are generally bullish on $COHR, with four recent buy ratings and a median price target of $88.0.

Analysis

A director at Coherent Corp. ($COHR), Howard H. Xia, recently divested 1,000 shares on June 11, 2025, for an estimated $83,000, equating to approximately $83.00 per share and reducing his holdings by 2.1% to 47,747 shares. This transaction is part of a broader pattern of insider activity at $COHR, where insiders have exclusively sold shares over the past six months, totaling 11 sales and zero purchases; notable sales include 29,292 shares by Shaker Sadasivam and 14,196 shares by EVP Christopher Koeppen. In contrast to this insider selling pressure, Wall Street analysts maintain a bullish outlook, with four firms issuing buy-equivalent ratings in recent months and a median price target of $88.00 from two analysts, suggesting potential upside from Xia's sale price. Institutional ownership data from Q1 2025 reveals a divided sentiment among large investors: 320 institutions added to their $COHR positions while 355 reduced theirs. Significant divestments were made by Dodge & Cox, which cut its stake by 37.1% (3.8 million shares), and Whale Rock Capital Management, which reduced its holding by 79.1% (1.7 million shares). Conversely, Wellington Management Group increased its position by 83.8% (2.6 million shares), and Point72 Asset Management boosted its stake by 122.6% (1.9 million shares). Adding another layer, members of Congress have shown modest buying interest, with Senator Markwayne Mullin making three purchases totaling up to $115,000 in the last six months. Overall, $COHR presents a mixed signaling environment, characterized by consistent insider sales, divergent institutional investor actions, but strong positive sentiment from sell-side analysts and minor bullish congressional trading.

Key Decisions for Investors

• Investors should carefully weigh the persistent pattern of insider sales, including the recent director's sale at $83.00 per share, against the uniformly bullish analyst ratings which suggest a median price target of $88.00.
• The significant and conflicting institutional capital flows in Q1 2025, with major funds both substantially increasing and decreasing positions, warrant close monitoring of subsequent 13F filings to gauge shifts in large investor conviction.
• Given the divergence between heavy insider selling (11 sales, 0 buys in six months) and positive external indicators like analyst ratings and minor congressional buying, a cautious approach may be prudent until fundamental catalysts or company guidance provide clearer direction.